CVS Health said it issued and sold $2,250,000,000 aggregate principal amount of its 7.000% Fixed-to-Fixed Rate Series A Junior Subordinated Notes due 2055 on December 10, 2024.

1. 01

   CVS Health said it issued and sold $2,250,000,000 aggregate principal amount of its 7.000% Fixed-to-Fixed Rate Series A Junior Subordinated Notes due 2055 on December 10, 2024.

2. 02

   The company said it issued and sold $750,000,000 aggregate principal amount of its 6.750% Fixed-to-Fixed Rate Series B Junior Subordinated Notes due 2054 on the same day.

3. 03

   It said the Notes were offered under Form S-3ASR registration statement (File No. 333-272200) filed on May 25, 2023, and were issued under a Subordinated Indenture dated May 25, 2007 as the base indenture.

4. 04

   CVS Health said the Series A notes are governed by the Second Supplemental Indenture and the Series B notes by the Third Supplemental Indenture, each dated December 10, 2024, and that it filed the indentures and forms of the notes as Exhibits 4.1 to 4.5.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.